1. Home
  2. CTM vs ESLA Comparison

CTM vs ESLA Comparison

Compare CTM & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

HOLD

Current Price

$0.71

Market Cap

63.1M

Sector

Technology

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

N/A

Current Price

$1.14

Market Cap

69.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTM
ESLA
Founded
2019
2021
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
69.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CTM
ESLA
Price
$0.71
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
1.6M
28.4K
Earning Date
05-08-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
N/A
EPS
N/A
N/A
Revenue
$52,866,001.00
N/A
Revenue This Year
$20.36
N/A
Revenue Next Year
$6.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.10
N/A
52 Week Low
$0.48
$0.78
52 Week High
$1.56
$3.15

Technical Indicators

Market Signals
Indicator
CTM
ESLA
Relative Strength Index (RSI) 45.32 42.52
Support Level $0.63 $0.98
Resistance Level $0.78 $1.31
Average True Range (ATR) 0.06 0.09
MACD -0.00 0.01
Stochastic Oscillator 28.09 50.00

Price Performance

Historical Comparison
CTM
ESLA

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Share on Social Networks: